Root Financial Partners
RLAY icon

Root Financial Partners’s Relay Therapeutics RLAY Stock Holding History

Root Financial Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.82K Buy
+101
New +$1.94K ﹤0.01% 2690
2026
Q2 		– Sell
-93
Closed -$925 – 2565
2026
Q1 		$925 Buy
+93
New +$832 ﹤0.01% 2639

Other funds holding RLAY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Zweig-DiMenna Associates
Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Root Financial Partners's RLAY Position: Q3 2026 in Review

Root Financial Partners opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 101 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #2690 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in RLAY as recently as Q1 2026.

Root Financial Partners first reported a position in RLAY in Q1 2026 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • Root Financial Partners held 101 shares of Relay Therapeutics worth $1.82K as of Q3 2026.
  • Relay Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Relay Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2690 holding.
  • Root Financial Partners first reported a position in Relay Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.